List of Excipients in API levonorgestrel/ethinyl estradiol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing levonorgestrel/ethinyl estradiol
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Agile Therapeutics Inc | TWIRLA | levonorgestrel/ethinyl estradiol | 71671-100 | CAPRIC ACID | |
| Agile Therapeutics Inc | TWIRLA | levonorgestrel/ethinyl estradiol | 71671-100 | COPOVIDONE K25-31 | |
| Agile Therapeutics Inc | TWIRLA | levonorgestrel/ethinyl estradiol | 71671-100 | CROSPOVIDONE | |
| Agile Therapeutics Inc | TWIRLA | levonorgestrel/ethinyl estradiol | 71671-100 | DIMETHYL SULFOXIDE | |
| Agile Therapeutics Inc | TWIRLA | levonorgestrel/ethinyl estradiol | 71671-100 | ETHYL LACTATE | |
| Agile Therapeutics Inc | TWIRLA | levonorgestrel/ethinyl estradiol | 71671-100 | HEPTANE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for levonorgestrel/ethinyl estradiol
Excipient focus: CAPRIC ACID
levonorgestrel/ethinyl estradiol drug variants containing CAPRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Agile Therapeutics Inc | levonorgestrel/ethinyl estradiol | 71671-100 |
| >Company | >Ingredient | >NDC |
levonorgestrel/ethinyl estradiol drug variants not containing CAPRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
levonorgestrel/ethinyl estradiol drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Agile Therapeutics Inc | levonorgestrel/ethinyl estradiol | 71671-100 |
| >Company | >Ingredient | >NDC |
levonorgestrel/ethinyl estradiol drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
levonorgestrel/ethinyl estradiol drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Agile Therapeutics Inc | levonorgestrel/ethinyl estradiol | 71671-100 |
| >Company | >Ingredient | >NDC |
levonorgestrel/ethinyl estradiol drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHYL SULFOXIDE
levonorgestrel/ethinyl estradiol drug variants containing DIMETHYL SULFOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Agile Therapeutics Inc | levonorgestrel/ethinyl estradiol | 71671-100 |
| >Company | >Ingredient | >NDC |
levonorgestrel/ethinyl estradiol drug variants not containing DIMETHYL SULFOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYL LACTATE
levonorgestrel/ethinyl estradiol drug variants containing ETHYL LACTATE
| Company | Ingredient | NDC |
|---|---|---|
| Agile Therapeutics Inc | levonorgestrel/ethinyl estradiol | 71671-100 |
| >Company | >Ingredient | >NDC |
levonorgestrel/ethinyl estradiol drug variants not containing ETHYL LACTATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HEPTANE
levonorgestrel/ethinyl estradiol drug variants containing HEPTANE
| Company | Ingredient | NDC |
|---|---|---|
| Agile Therapeutics Inc | levonorgestrel/ethinyl estradiol | 71671-100 |
| >Company | >Ingredient | >NDC |
levonorgestrel/ethinyl estradiol drug variants not containing HEPTANE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LAURYL LACTATE
levonorgestrel/ethinyl estradiol drug variants containing LAURYL LACTATE
| Company | Ingredient | NDC |
|---|---|---|
| Agile Therapeutics Inc | levonorgestrel/ethinyl estradiol | 71671-100 |
| >Company | >Ingredient | >NDC |
levonorgestrel/ethinyl estradiol drug variants not containing LAURYL LACTATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
levonorgestrel/ethinyl estradiol drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Agile Therapeutics Inc | levonorgestrel/ethinyl estradiol | 71671-100 |
| >Company | >Ingredient | >NDC |
levonorgestrel/ethinyl estradiol drug variants not containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYBUTENE
levonorgestrel/ethinyl estradiol drug variants containing POLYBUTENE
| Company | Ingredient | NDC |
|---|---|---|
| Agile Therapeutics Inc | levonorgestrel/ethinyl estradiol | 71671-100 |
| >Company | >Ingredient | >NDC |
levonorgestrel/ethinyl estradiol drug variants not containing POLYBUTENE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYISOBUTYLENE
levonorgestrel/ethinyl estradiol drug variants containing POLYISOBUTYLENE
| Company | Ingredient | NDC |
|---|---|---|
| Agile Therapeutics Inc | levonorgestrel/ethinyl estradiol | 71671-100 |
| >Company | >Ingredient | >NDC |
levonorgestrel/ethinyl estradiol drug variants not containing POLYISOBUTYLENE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch